SCHEMBL4456587

SCHEMBL4456587

Nc1nn(-c2ccc(Cl)cc2)cc1NC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.48
ALDH1A1 P00352 4/20 0.48
MAPT P10636 3/20 0.48
LMNA P02545 3/20 0.48
HPGD P15428 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
KMT2A Q03164 2/20 0.48
GAA P10253 1/20 0.48
PKM P14618 1/20 0.48
HDAC1 Q13547 3/20 0.46
HDAC2 Q92769 3/20 0.46
AURKA O14965 5/20 0.43
ADORA3 P0DMS8 1/20 0.43
ADORA2A P29274 1/20 0.43
PARP1 P09874 1/20 0.43
PARP2 Q9UGN5 1/20 0.43
PARP3 Q9Y6F1 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14312439 0.87 LMNA (0.49) KDM4EALDH1A1LMNANPC1RAB9A
SCHEMBL5137092 0.87 HDAC1 (0.41) KDM4EALDH1A1MAPTLMNAHPGD
SCHEMBL2887260 0.86 HDAC1 (0.57) KDM4EALDH1A1MAPTLMNAHPGD
SCHEMBL4454941 0.85 HDAC1 (0.58) KDM4EALDH1A1MAPTLMNANPC1
SCHEMBL3999180 0.85 PARP1 (0.48) KDM4EALDH1A1MAPTLMNAHPGD
SCHEMBL14312270 0.82 MAPKAPK2 (0.54) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL12291140 0.80 KDM4E (0.41) KDM4EALDH1A1MAPTLMNAHPGD
SCHEMBL14312436 0.78 KDM4E (0.46) KDM4EALDH1A1MAPTLMNAHPGD
SCHEMBL14312424 0.78 HDAC1 (0.41) KDM4EALDH1A1MAPTLMNAHPGD
SCHEMBL14312428 0.77 HDAC1 (0.41) KDM4EALDH1A1MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945617-B1 HISTONE DEACETYLASE INHIBITORS WITH ARYL-PYRAZOLYL MOTIFS MERCK SHARP & DOHME (US) 2012-12-26 EP disclosed
US-20090291965-A1 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs MERCK SHARP & DOHME LLC 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291965-A1 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs HDAC1, HDAC3, HDAC5 KDM4E 97/4885ALDH1A1 540/4885MAPT 3866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.